Grape seed proanthocyanidin extract protects against carrageenan-induced lung inflammation in mice through reduction of pro-inflammatory markers and chemokine expressions

Inflammation

Volumn 37, Issue 2, 2014, Pages 500-511

  Ahmad, Sheikh Fayaz ^a   Zoheir, Khairy M A ^a,b   Abdel Hamied, Hala E ^c   Attia, Sabry M ^a,d   Bakheet, Saleh A ^a   Ashour, Abdelkader E ^a   Abd Allah, Adel R A ^a,d  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c AL AZHAR UNIVERSITY   (Egypt)

^d Al Azhar University   (Egypt)

Author keywords

carrageenan; cytokines; GITR; grape seed proanthocyanidin extract; lung; pleural exudate

Indexed keywords

BIOLOGICAL MARKER; CARRAGEENAN; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GRAPE SEED EXTRACT; GRAPE SEED PROANTHOCYANIDIN EXTRACT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROANTHOCYANIDIN DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARRAGEENAN-INDUCED PLEURISY; CELL COUNT; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOLOGY; MOUSE; NONHUMAN; PLEURA FLUID; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; GRAPE SEED EXTRACT; INFLAMMATION MEDIATORS; LUNG; MICE; MICE, INBRED BALB C; PLEURISY; PNEUMONIA; PROANTHOCYANIDINS; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84896396547     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9764-2     Document Type: Article

References (34)

1. Fine, A.M. 2000. Oligomeric proanthocyanidin complexes: History, structure, and phytopharmaceutical applications. Alternative Medicine Review 5: 144-151.
2. Bagchi, D.; M. Bagchi, S.J. Stohs, S.D. Ray, C.K. Sen, and H.G. Preuss. 2002. Cellular protection with proanthocyanidins derived from grape seeds. The New York Academy of Sciences 957: 260-270.
3. Zhang, Y.Y.; W.G. Li, Y.J. Wu, D.C. Bai, and N.F. Liu. 2005. Proanthocyanidin from grape seeds enhances doxorubicin-induced antitumor effect and reverses drug resistance in doxorubicin-resistant K562/DOX cells. Canadian Journal of Physiology and Pharmacology 83: 309-318.
4. Clarke, C.J.; A. Hales, A. Hunt, and B.M. Foxwell. 1998. IL-10- mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. European Journal of Immunology 28: 1719-1726.
5. Shin, D.I.; U. Banning, and Y.M. Kim. 1999. Interleukin 10 inhibits TNF-alpha production in human monocytes independently of interleukin 12 and interleukin 1 beta. Immunological Investigations 28: 165-175.
6. Kebir, H.; K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, M. Bernard, F. Giulian, N. Arbour, B. Becher, and A. Prat. 2007. Human Th17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nature Medicine 13: 1173-1175.
7. Toh, M.L.; and P. Miossec. 2007. The role of T cells in rheumatoid arthritis: New subsets and new targets. Current Opinion in Rheumatology 19: 284-288.
8. Komiyama, Y.; S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. The Journal of Immunology 177: 566-573.
9. Christopherson, K.; and R. Hromas. 2001. Chemokine regulation of normal and pathologic immune responses. Stem Cells 19: 388-396.
10. Nocentini, G.; and C. Riccardi. 2005. A multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. European Journal of Immunology 35(4): 1016-1022.
11. Hanabuchi, S.; N. Watanabe, Y.H. Wang, Y.H. Wang, T. Ito, J. Shaw, W. Cao, F.X. Qin, and Y.J. Liu. 2006. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood 107(9): 3617-3623.
12. Lentsch, A.B.; and P.A. Ward. 2001. Regulation of experimental lung inflammation. Respiration Physiology 128: 17-21.
13. Saleh, T.S.; J.B. Calixto, and Y.S. Medeiros. 1996. Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy. British Journal of Pharmacology 118: 811-819.
14. Lunardelli, A.; C.E. Leite, M.G.S. Pires, and J.R. Oliveira. 2006. Extract of the bristles of Dirphia sp. increases nitric oxide in a rat pleurisy model. Inflammation Research 55: 129-135.
15. Paul, E.L.; A. Lunardelli, E. Caberlon, C.B. Oliveira, R.C.V. Santos, V. Biolchi, C.M.A. Bastos, K.B. Moreira, F.B. Nunes, G. Gosmann, and J.R. Oliveira. 2009. Anti-inflammatory and immunomodulatory effects of Baccharis trimera aqueous extract on induced pleurisy in rats and lymphoproliferation in vitro. Inflammation 32(6): 419-425.
16. Katz, Y.; O. Nadiv, and Y. Beer. 2001. Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukin 1, 6, and 8 in skin and synovial fibroblasts: A possible role as a "finetuning cytokine" in inflammation processes. Arthritis and Rheumatism 44: 2176-2184.
17. Bandt, M.D.; M. Grossin, F. Driss, J. Pincemail, C. Babin-Chevaye, and C. Pasquier. 2002. Vitamin E uncouples joint destruction and clinical inflammation in a transgenic mouse model of rheumatoid arthritis. Arthritis and Rheumatism 46: 522-532.
18. Lee, E.Y.; C.K. Lee, K.U. Lee, J.Y. Park, K.J. Cho, and Y.S. Cho. 2007. Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice. Rheumatology International 27: 225-233.
19. Koshy, P.J.; N. Henderson, C. Logan, P.F. Life, T.E. Cawston, and A.D. Rowan. 2002. Interleukin 17 induces cartilage collagen breakdown: Novel synergistic effects in combination with proinflammatory cytokines. Annals of the Rheumatic Diseases 61: 704-713.
20. Hurst, S.D.; T. Muchamuel, D.M. Gorman, J.M. Gilbert, T. Clifford, S. Kwan, S. Menon, B. Seymour, C. Jackson, T.T. Kung, J.K. Brieland, S.M. Zurawski, R.W. Chapman, G. Zurawski, R.L. Coffman. 2002. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. The Journal of Immunology 443-453.
21. Li, L.; A.L.L. Huang, H. Vergis, A. Ye, V. Bajwa, R.M. Narayan, D.L. Strieter, and M.D. Okusa Rosin. 2010. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. Journal of Clinical Investigation 120: 331-342.
22. Zhao, L.; J.Y. Tao, S.L. Zhang, R. Pang, F. Jin, J.H. Dong, and Y.J. Guo. 2007. Inner anti-inflammatory mechanisms of petroleum ether extract from Melilotus suaveolens Ledeb. Inflammation 30: 213-223.
23. Alonzi, T.; E. Fattori, M. Cappelletti, G. Ciliberto, and V. Poli. 1998. Impaired stat3 activation following localized inflammatory stimulus in IL-6 deficient mice. Cytokine 10: 13-18.
24. Borish, L.C.; and J.W. Steinke. 2003. Cytokines and chemokines. Journal of Allergy and Clinical Immunology 111: 460-475.
25. Morioka, N.; A. Inoue, T. Hanada, K. Kumagai, K. Takeda, K. Ikoma, I. Hide, Y. Tamura, H. Shiomi, T. Dohi, and Y. Nakata. 2002. Nitric oxide synergistically potentiates interleukin-1 beta-induced increase of cyclooxigenase-2 mRNA levels, resulting in the facilitation of substance P release from primary afferent neurons: Involvement of cGMP-independent mechanisms. Neuropharmacology 43: 868-876.
26. Menegazzi, M.; R. Di Paola, E. Mazzon, T. Genovese, and C. Crisafulli. 2008. Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice. Pharmacological Research 58: 22-31.
27. Calcagni, E.; and I. Elenkov. 2006. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Annals of the New York Academy of Sciences 1069: 62-76.
28. Stow, J.L.; P.C. Low, C. Offenhauser, and D. Sangermani. 2009. Cytokine secretion in macrophages and other cells: Pathways and mediators. Immunobiology 214: 601-612.
29. Wuyts, A.; P. Proost, J.P. Put, L. Lenaerts, and J. van Damme. 1994. Leukocyte recruitment by monocyte W. chemotactic proteins (MCPs) secreted by human phagocytes. Journal of Immunological Methods 174: 237-247.
30. Cuzzocrea, S.; E. Mazzon, G. Calabro, L. Dugo, A. Sarro, F.A.J.V. Loo, and P.C. Achille. 2000. Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan. American Journal of Respiratory and Critical Care Medicine 162: 1859-1866.
31. Oberholzer, A.; C. Oberholzer, and L.L. Moldawer. 2002. Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Critical Care Medicine 30(1 Suppl): S58-S63.
32. Frode, T.S.; G.E. Souza, and J.B. Calixto. 2002. The effects of IL-6 and IL-10 and their specific antibodies in the acute inflammatory responses induced by carrageenan in the mouse model of pleurisy. Cytokine 17: 149-156.
33. Kelley, J. 1993. Transforming growth factor-beta. In Cytokines of the lung, ed. J. Kelley, 101-137. New York: Marcel Dekker.
34. Stapelberg, M.; N. Gellert, and E. Swettenham. 2005. Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: Mechanism and the role of oxidative stress. The Journal of Biological Chemistry 280: 25369-25376.